PMID: 18409533Apr 16, 2008Paper

New treatment for spasticity--intrathecal baclofen therapy

Nihon rinsho. Japanese journal of clinical medicine
Akinobu Nemoto, Katsumi Sakata

Abstract

Since its introduction in the late 1980s, intrathecal baclofen(ITB) therapy has become the standard treatment for severe generalized spasticity of both spinal and cerebral origin. More than 50,000 pumps were implanted in the world. Long term efficacy of ITB therapy is excellent, although it is frequently associated with complications such as infections, catheter malfunctions, and cerebrospinal fluid leaks. There are some reports of death with withdrawal, overdose and infection. For a good results we need to discuss factors involved in selecting the appropriate treatment modalities for the individual. The treatment of these patients is optimized in the setting of a multidisciplinary team.

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Related Papers

Neurosurgical Focus
A Leland Albright, S S Ferson
Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
Neil HaranhalliJonathan Roth
Archives of Physical Medicine and Rehabilitation
Nancy A MurphyCharles Hoff
© 2022 Meta ULC. All rights reserved